本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Revolution Medicines, Inc.

46.55
+0.31000.67%
盤後46.980.4300+0.92%19:17 EDT
成交量:363.23萬
成交額:1.68億
市值:87.02億
市盈率:-10.29
高:47.04
開:46.80
低:45.18
收:46.24
52周最高:62.40
52周最低:29.17
股本:1.87億
流通股本:1.59億
量比:1.58
換手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
淨資產收益率:-46.61%
總資產收益率:-26.47%
市淨率:4.66
市盈率(LYR):-13.01

資料載入中...

2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/01

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/07/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/06

SEC問詢函

CORRESP [Cover] - Correspondence